3, 4-substituted pyrrolidine derivatives for the treatment of hypertension

Details for Australian Patent Application No. 2006226554 (hide)

Owner Novartis AG

Inventors Irie, Osamu; Ostermann, Nils; Lorthiois, Edwige Liliane Jeanne; Sellner, Holger; Maibaum, Juergen Klaus; Ehrhardt, Claus

Agent Davies Collison Cave

Pub. Number AU-B-2006226554

PCT Pub. Number WO2006/100036

Priority 0505969.6 23.03.05 GB

Filing date 21 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 11 March 2010

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/4035 (2006.01)

A61K 31/404 (2006.01)

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/454 (2006.01)

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/5377 (2006.01)

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/27 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100036 Priority application(s): WO2006/100036

11 March 2010 Application Accepted

  Published as AU-B-2006226554

8 July 2010 Standard Patent Sealed

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226577-Process for the production of methylcobalamin

2006226544-2-oxo-1,2,4,5-tetrahydro-1,3-benzodiaz epin-3-yl-piperidines used as CGRP antagonists